Cryptotanshinone protects dextran sulfate sodium-induced experimental ulcerative colitis in mice by inhibiting intestinal inflammation
- 1 October 2020
- journal article
- research article
- Published by Wiley in Phytotherapy Research
- Vol. 34 (10), 2639-2648
- https://doi.org/10.1002/ptr.6693
Abstract
The incidence of ulcerative colitis (UC) is increasing in recent years. The protective effect of cryptotanshinone, a natural compound from Salvia miltiorrhiza Bunge, on UC was investigated both in vivo and in vitro models. UC model was established by dextran sulfate sodium administration in drinking water and cryptotanshinone was orally administrated. RAW264.7 cells were stimulated by lipopolysaccharide (LPS) with or without cryptotanshinone pretreatment. The body weights and disease activity index (DAI) were recorded. The pathological alterations were evaluated by H&E staining. The levels of pro-inflammatory cytokines in colon tissues and cell culture medium were determined with enzyme-linked immune sorbent assay (ELISA) kits. The protein expression was detected by Western blotting and immunohistochemistry. Results showed that cryptotanshinone significantly increased the body weight and colon length, reduced the score of DAI, and improved pathological changes. Furthermore, the expression of inducible nitric oxide synthase, cyclooxygenase-2, receptor-interacting protein kinase 3, NF-kappa B p65 and the secretion of tumor necrosis factor-alpha, IL-6 in colon tissues and LPS-stimulated cells were significantly inhibited by cryptotanshinone. Besides, cryptotanshinone significantly inhibited LPS-triggered toll-like receptor 4 luciferase reporter activity with an IC50 at 7.2 mu M. In conclusion, cryptotanshinone ameliorated experimental UC possibly by inhibiting intestinal inflammation.Keywords
Funding Information
- National Natural Science Foundation of China (81774200)
This publication has 45 references indexed in Scilit:
- A comprehensive review and update on ulcerative colitis,Disease-a-Month, 2019
- Cryptotanshinone inhibits prostaglandin E2 production and COX-2 expression via suppression of TLR4/NF-kappa B signaling pathway in LPS-stimulated Caco-2 cellsMicrobial Pathogenesis, 2018
- Dextran sodium sulfate colitis murine model: An indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesisWorld Journal of Gastroenterology, 2017
- Regulated necrosis: disease relevance and therapeutic opportunitiesNature Reviews Drug Discovery, 2016
- The Anticancer Properties of Salvia Miltiorrhiza Bunge (Danshen): A Systematic ReviewMedicinal Research Reviews, 2014
- Anti-IL-6 Treatment for Inflammatory Bowel Diseases: Next Cytokine, Next TargetCurrent Drug Targets, 2013
- Molecular evidence of cryptotanshinone for treatment and prevention of human cancer.Anti-Cancer Agents in Medicinal Chemistry, 2013
- NF‐κB in inflammatory bowel diseaseJournal of Internal Medicine, 2008
- Tanshinone IIA Ameliorates Trinitrobenzene Sulfonic Acid (TNBS)-Induced Murine ColitisDigestive Diseases and Sciences, 2007
- Toll‐Like Receptor Signaling and its Relevance to Intestinal InflammationAnnals of the New York Academy of Sciences, 2006